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Abstract 
In a Norwegian prospective population-based cohort study, we examined whether the number 
of chronic musculoskeletal pain sites changed over an 11-year period, and if the number of 
pain sites at follow-up was associated with health-related and lifestyle factors at baseline. The 
study included data on 78,973 adults participating in the Nord-Trøndelag Health Study 
(HUNT) in 1995–1997 (HUNT2) and 2006–2008 (HUNT3). Based on three categories of 
baseline pain sites, associations between baseline health-related, lifestyle, and demographic 
factors and number of pain sites at follow-up were analysed with linear regression models 
adjusted for age, sex, marital status, physical activity, education, and other chronic diseases. 
We also estimated within-subject associations. Regardless of pain extent at baseline, anxiety 
and/or depression, sleeping problems, smoking, and obesity were positively associated with 
number of pain sites at follow-up, while education and physical activity were inversely 
associated with number of pain sites. The within-subject analyses showed largely similar 
associations for the health-related factors, whereas associations of lifestyle factors were 
attenuated. The mean number of pain sites remained unchanged between the two surveys. 
Overall, our study revealed prospective associations between several factors and pain sites 11 
years later, regardless of the number of pain sites at baseline. 
 
Perspective 
This prospective study examines the association between development of pain and risk factors 
in the general population, on the basis of three categories of baseline pain sites. It also 
examines how these factors influence possible long-term changes in pain within individuals. 
We demonstrate that having no or few baseline pain sites may not differ in its risk factors 
compared with having multiple pain sites. This article provides an important contribution to 
the ongoing debate regarding the association between lifestyle, demographic, and 
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psychosocial risk factors, versus the course of multisite chronic pain.  Additionally, we 
provide discussion on potential directions for clinical relevance and further research in this 
field. 
 
Keywords 
Chronic musculoskeletal pain; Pain; Risk factors; General population; Prospective 
epidemiologic study 
 
 
Introduction  
 
The more pain sites an individual reports, the more severe are the functional, physical, 
psychological, neurocognitive, and social consequences experienced, regardless of pain 
location.1, 23, 35, 39 Recent research also suggests that there are important differences in the risk 
factors for single-site pain and widespread pain, and that the overall consequences are highly 
dependent on number of pain sites.8, 24 Indeed, chronic pain can be classified as regional or 
widespread, depending on the number of pain sites affected.2, 7, 23  Regional pain appears as 
single pain sites in, e.g., lower back, shoulder, or neck, with lower back and neck pain as the 
most frequently reported sites, 11, 24 whereas widespread pain has commonly been categorized 
as pain in the trunk, in upper and lower limbs, and on both sides of the body.52 
 
There is equivocal evidence regarding population-level changes in the prevalence of 
musculoskeletal pain over time. A UK study indicated a substantial increase in the prevalence 
of musculoskeletal pain between two cross-sectional surveys conducted over 40 years apart.22 
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However, other studies have indicated small changes over time.18, 20, 37 It is difficult to assess 
differences in prevalence between cross-sectional studies. Differences can be sensitive to 
changes in survey methods and representativeness. Taking advantage of repeated measures of 
pain within individuals could be one possible way to overcome such analytical problems.47, 54 
 
At the individual level, chronic musculoskeletal pain might spread between body regions.1 
However, a Norwegian study suggested a highly stable number of pain sites over time, and 
that previous multisite pain appeared as a strong predictor of future multisite pain, 
independent of sex, age, sleep quality, and education.23 A multinational cross-sectional study 
reported progressively stronger associations between physical and psychosocial risk factors 
and an increasing number of pain sites.8 Female sex, anxiety and depression, sleeping 
problems, smoking, overweight/obesity, and family history of pain are also known risk factors 
for chronic widespread pain (CWP).3, 32, 45  
 
Chronic musculoskeletal pain is complex and determined by multiple causal pathways 
involving biological, psychological, and social influences that can interact with each other.13, 
17, 34
 Yet the full aetiology is unclear.49 In addition, the classification of multisite pain is not 
clearly defined, usually taken to be two or more sites,7 which challenges comparability. It is 
not clear how the number of pain sites change over time and if there are factors that influence 
these changes from the extent of baseline pain.  
 
This large population-based prospective study aims to (1) study long-term changes in the 
mean number of musculoskeletal pain sites, relative to the influence of demographic, lifestyle, 
and morbidity variables, and (2) examine the development of musculoskeletal pain in terms of 
number of pain sites within individuals over an 11-year period according to the same risk 
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factors. Examining these associations over time within individuals prevents confounding 
related to factors that remain stable within individuals (such as sex, occupation, genetic make-
up, presence of chronic disease) because each individual serves as her/his own control. 
 
Methods  
 
Study population 
The HUNT study (“Helseundersøkelsen i Nord-Trøndelag”) was designed as a longitudinal 
cohort study consisting of three health surveys carried out at 11-year intervals in which all 
residents aged 20 years and older in Norway’s Nord-Trøndelag County were invited to 
participate.28 Since the first survey (HUNT1, 1984–86) did not collect information on 
musculoskeletal pain, it is not included in the current analysis. The present study was based 
on data from the second (HUNT2, 1995–1997) and third (HUNT3, 2006–2008) surveys. Data 
in all HUNT surveys were collected through interviews, self-administrated questionnaires, 
and clinical examinations with measures of weight, height, waist and hip circumference, 
blood pressure, and heart rate.21, 29 
 
Participation in HUNT2 and HUNT3 was defined as having completed questionnaire 1 (Q1) 
and having provided written consent regarding the screening, subsequent follow-up, and data 
linkages to other registers. The study population comprised 78,973 individuals who 
participated in either HUNT2 or HUNT3, or in both surveys. More specifically, 65,237 
(69.5% of those invited) participated in HUNT2, and 50,807 (54.1%) participated in HUNT3. 
A total of 37,071 individuals participated in both surveys. Of those, 26,875 participants had 
complete information. The distribution of the eligible participants and the inclusion process is 
illustrated in Figure 1.  
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                           Figure 1 
 
Study variables 
In both HUNT2 and HUNT3, information on chronic musculoskeletal pain was obtained from 
the Standardized Nordic Questionnaire (SNQ).30 The SNQ has been considered a reliable and 
sensitive screening instrument for investigating musculoskeletal symptoms, having excellent 
sensitivity and moderate specificity when assessing the agreement between questionnaires and 
clinical examination, and with high utility and generalizability in the screening context in 
epidemiological surveys and surveillance.10, 18, 46 If a participant confirmed the introductory 
question, “During the last year, have you had pain and/or stiffness in your muscles and limbs 
that has lasted for at least three consecutive months?”, they were then asked to specify 
whether pain was present in any of the nine different body regions: neck, shoulder, elbow, 
hand/wrist, upper back, lower back, hip, knee, and ankle/foot. If the participants responded 
only to the introductory pain question, without specifying their pain locations, they were 
defined as missing observations. Based on the introductory pain question in HUNT2 and 
HUNT3, we defined chronic pain as “having pain that has lasted for at least three consecutive 
months during the last year”. The number of pain sites was classified as “no pain”, “1–2 pain 
sites”, and “3 or more pain sites”, to examine whether the level of baseline pain sites is of 
importance for prospective associations. The categorization of pain sites into three pain 
categories reached a balance between categorization and power. The choice was determined 
by the number of pain sites,  not by the pain localizations. The categorization of pain sites has 
been motivated by Coggon et al.’s classification of pain.8 Having 1–2 pain sites at baseline 
represents limited pain, whilst 3 or more pain sites will include, but not be limited to, those 
with pain consistent with American College of Rheumatology (ACR) criteria of CWP.52  
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Lifestyle and health-related factors  
Information on age and marital status was obtained from the National Population Registry. 
Marital status was categorized as “single/divorced/separated/widower” and 
“married/cohabitant/partnership”.  
 
Information on mood was collected from the Hospital Anxiety and Depression Scale (HADS), 
which comprises seven items for depression (HADS-D) and seven items for anxiety (HADS-
A).58  According to a HADS validity study 4, the best balance between sensitivity (0.80) and 
specificity (0.80) was achieved when setting the cut-off score at ≥ 8, which marks a 
borderline case of anxiety or depression on the sub-scales. A score of  ≥8 on each subscale 
indicates clinically relevant symptoms consistent with depression (HADS-D) or anxiety 
(HADS-A).57  In this study, we wanted to examine the co-occurrence of clinically relevant 
anxiety and/or depression symptoms alongside chronic musculoskeletal pain. Based on this 
recommended cut-off score of ≥ 8 for each subscale,4 we categorized anxiety and depression 
into four groups: 1) neither anxiety nor depression, 2) depression only, 3) anxiety only, and 4) 
both depression and anxiety. We also utilized  the continuous scores of the HADS-subscales.  
As a sensitivity analysis, we also investigated the associations between different levels of 
anxiety and depression symptoms and number of pain sites. Ordinal variables for anxiety and 
depression symptom load were computed as reference (0–4), sub-symptom load, (5–7) mild 
symptom load (8–10), moderate symptom load (11–14), and severe symptom load (15–21).4, 
27
 Sleeping problems were identified by two questions: “Have you had difficulty falling 
asleep in the last month?” and “During the last month, have you woken too early and not been 
able to get back to sleep?”. Response options were “almost every night”, “often”, “now and 
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again”, and “never”. People reporting “almost every night” and “often” on either of these 
questions were classified as having sleeping problems. Long-term illnesses (other chronic 
diseases) were detected by the question: “Do you suffer from any long-term illness or injury 
of a physical or psychological nature that impairs your functioning in everyday life?”. 
 
Alcohol use was measured by the two questions: “Concerning alcohol, are you a non-
drinker?” and “How many times a month do you normally drink alcohol?”. Responses were 
classified as 1) zero times/ month, 2) 1–7 times/ month, 3) ≥ 8 times/ month, and 4) 
abstainers. Body mass index (BMI) was calculated as weight (kg) divided by the square of 
height (m) and classified according to the World Health Organization’s recommendations:55 
underweight (< 18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 
kg/m2), and obesity ( ≥ 30 kg/m2).51 Additionally, BMI was analysed as a continuous variable. 
Smoking was categorized into three groups: 1) “never smoking”, 2) “former smoking”, and 3) 
“current smoker”. Education was classified as 1) primary school, 2) high school, and 3) 
university/college.  Leisure-time physical activity was identified by the question: “Think of a 
weekly average for the year. How has your leisure-time physical activity been the last year?”. 
This question sought to discern between light activity (no sweating or being out of breath) per 
week, versus hard physical activity (sweating/out of breath), according to the average number 
of hours of exercise per week. The response options were “never”, “less than 1”, “1–2”, and 
“3 hours or more per week”. The level of physical activity was merged into a summary 
variable and computed as the average hours of low and hard physical activity per week during 
the last year, and classified into two groups: 1) “inactive” and 2) “active” (at least 30 minutes 
per day).31  
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Statistical analysis 
First, we presented a descriptive analysis of the change in number of pain sites, from 0 (no 
pain) to 9 pain sites for those who participated in both HUNT2 and HUNT3. We then 
performed a linear regression analysis and finally a multilevel linear regression analysis to 
investigate the mean difference in number of pain sites between HUNT2 and HUNT3 
according to different risk factors reported in HUNT2 and taking into account those 
participants with repeated measures between surveys. As a measure of within-person stability, 
we calculated the degree of clustering for number of pain sites among individuals, using the 
intra-class correlation coefficient (ICC), which reflected the proportion of pain site variance 
attributable to stability within individuals.47 In an extreme situation where there is no 
concordance in number of pain sites within individuals, the ICC would be zero, whereas if all 
individuals participating in the two surveys had the same value at each time point, then the 
ICC would equal one. 
 
In the next step of the analyses, we used a linear regression analysis to examine possible 
differences in risk factors for different numbers of baseline pain sites. These analyses were 
conditioned on 0, 1–2, or 3 or more reported pain sites in HUNT2. The levels of adjustment 
were carried out to assess the importance of potential confounders. In the first model (data not 
shown), each variable was adjusted for age and sex. In a fully adjusted model, we controlled 
for marital status, education, physical activity, and chronic disease in HUNT2, in addition to 
age and sex. Age and sex are considered potential confounding variables since they are 
associated with both the risk of developing chronic pain (higher prevalence with age and in 
females) and the exposure variables (e.g. sex differences in prevalence of anxiety and 
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depression symptoms, and increasing symptom load with age). Smoking and physical 
inactivity might also be a part of the same lifestyle leading to the risk of developing chronic 
musculoskeletal pain, and the same holds true for obesity and physical activity. 
Socioeconomic status (education) might be related to lifestyle and the incidence of chronic 
pain. Also, baseline chronic pain might account for the symptom load in, for instance, anxiety 
and depression, and in sleeping problems. Only complete cases were included in the 
regression analyses, as some participants did not report information on some of the included 
variables. Our outcome measure – i.e. number of pain sites – did not meet the formal 
assumption for linear regression analysis. As a sensitivity analysis, we also ran an ordered 
logistic regression model (Web table 2).  
 
Subsequently, we performed a within-individual linear fixed effect regression analysis of the 
mean change in number of pain sites in HUNT2 and HUNT3 according to change in different 
risk factors. The within-individual fixed effect linear regression analysis was adjusted for 
exercise and chronic disease, making it possible to control for all stable characteristics among 
the individuals (observed and unobserved). These models used a within-subject variation of 
the 26,875 participants with data from both time points,47 reflecting that the individuals were 
serving as their own control, and also used information on individuals discordant on exposure 
and outcome in the models. The central idea for employing a fixed effect model is to use each 
individual as his/her own control in order to eliminate between-individual differences that 
may be present in ordinary population analyses (between-subjects variation) in population 
analyses.  
 
All statistical analyses were performed with the statistical package Stata version 13.1 
(StataCorp, College Station, Texas, USA).  
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Ethics 
This study was approved by the Regional Norwegian Committee for Medical and Health 
Research Ethics and the National Data Inspectorate.  
 
Results  
 
Demographic data and characteristics of the two surveys (HUNT2 and HUNT3) are presented 
in Table 1. In the HUNT2 cohort (n=34,662, 53% female), 48% (n=30,976) of participants 
reported chronic musculoskeletal pain ranging from 1 to 9 pain sites, measured by the SNQ 
map, of which 57% (n=17,734) were female.  In HUNT2, 43% of those with chronic 
musculoskeletal pain reported 1 to 2 pain sites, and approximately 56% reported 3 or more 
pain sites (Table 1). Only 0.5 % of those reporting chronic musculoskeletal pain in HUNT2 or 
in HUNT3 did not specify their pain location and were thus excluded from the analyses. 
Chronic musculoskeletal pain was most prevalent in those aged 40–49 (21%).  
 
     Table 1 
 
Long-term course of chronic musculoskeletal pain sites 
Of those reporting no chronic pain in HUNT2, 62% (n=9,686) remained free of chronic pain 
in HUNT3 (Table 2). Of those reporting 1 to 2 sites of pain in HUNT2, 32% reported the 
same number of pain sites at follow-up, and the corresponding figure among those with ≥ 3 
sites in HUNT3 was 30%. Although the majority reported less pain at follow-up, the 
proportion who reported that all of their pain had resolved (i.e. zero pain sites) was small, and 
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this proportion decreased as the number of pain sites from HUNT2 increased. Of those who 
reported ≥ 3 sites in HUNT2, 63% continued to report ≥ 3 pain sites in HUNT3, with the 
remainder reporting less pain (16% reporting zero pain sites). Based on the results from a 
multilevel regression analysis, a total of 53% of the variability in pain sites could be attributed 
to stability within individuals (ICC=0.53, p<0.001), indicating a substantial stability in the 
number of pain sites within individuals over the 11-year period.   
 
Table 2   
 
Table 3 summarizes the fully adjusted 11-year prospective associations of subsequent number 
of pain sites conditional on number of pain sites reported at baseline. For those without 
baseline pain, anxiety and depression symptoms were associated with 0.54 (95% confidence 
interval (CI): 0.38 to 0.70) more pain sites in HUNT3, compared to the absence of these 
symptoms. A largely similar association was observed for people with only anxiety, whereas 
the association was weaker for those with only depression symptoms. These associations did 
not deviate substantially when based on number of pain sites in HUNT2. For continuous 
scores of HADS- subscales, one point change in depression was associated with 0.04 more 
pain sites for those without baseline pain (95% CI: 0.03 to 0.06). Similar associations were 
found  in those reporting 1-2 or 3 or more pain sites in HUNT3. In addition, the anxiety 
HADS-subscale and the total HADS-scale showed largely similar associations. The results 
from supplementary sensitivity analysis based on categories of anxiety and depression 
symptoms, rather than a binary variable using multivariable linear regression, are largely in 
line with the results presented above, except that the increasing levels of depression 
symptoms in those reporting no baseline pain were associated with an increase in the number 
of pain sites (from 0.30 (95% CI: 0.18 to 0.43) among those with mild symptoms of 
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depression, and up to 1.03 (95% CI: 0.36 to 1.70)) among those with severe symptoms, 
compared to those with no depression symptoms (data not shown). 
 
Among people without baseline pain, problems with initiating or maintaining sleep were 
associated with 0.38 (95% CI: 0.27 to 0,49) more pain sites in HUNT3 compared with no 
sleep problems. For those reporting 1–2 or 3 or more pain sites, sleep problems were 
associated with a  0.34 (95% CI: 0.18 to 0.50) and 0.56 (95% CI: 0.41 to 0.71) increase in the 
number of pain sites, respectively. 
 
Among people without baseline pain, the frequency of alcohol consumption was not 
associated with number of pain sites at follow-up. However, for those reporting 3 or more 
pain sites, drinking alcohol ≥ 8 times a month was associated with 0.29 (95% CI: -0.56 to -
0.01) fewer pain sites in HUNT3, versus those drinking zero times a month. Analyses of BMI 
showed that among people without pain at baseline, obesity was associated with 0.30 (95% 
CI: 0.21 to 0.38) more pain sites in HUNT3, compared to those of normal weight, and this 
relationship was stronger among those with 3 or more pain sites (0.44, 95% CI: 0.28 to 0.61). 
For continuous scores of BMI, one point change in BMI was associated with 0.03 more pain 
sites (95% CI: 0.02 to 0.03) in those without baseline pain, while among those reporting 1-2, 
and 3 or more baseline pain sites, one point change in BMI was associated with 0.02 (95% CI: 
0.01 to 0.04), and 0.04 (95% CI: 0.02 to 0.06) more pain sites at follow-up, respectively.  
 
Compared with never smoking, daily smoking was associated with 0.26 (95% CI: 0.20 to 
0.33) more pain sites at follow-up among people reporting no baseline pain, whereas the 
association was attenuated among those reporting ≥ 3 pain sites (0.13, 95% CI: -0.02 to 0.27). 
Physical activity was not associated with number of pain sites at follow-up among those free 
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of chronic pain at baseline. Yet it was inversely associated with number of pain sites among 
those reporting 1–2 pain sites (-0.15, 95% CI: -0.25 to -0.05) and (-0.12, 95% CI: -0.24 to -
0.00) among those reporting  ≥ 3 pain sites, compared with those who reported being inactive. 
Among people without baseline pain, education (comparing university/college education with 
primary school) was inversely associated with number of pain sites at follow-up (-0.30, 95% 
CI: -0.38 to -0.22). The strength of this association increased with an increase in the number 
of pain sites at baseline (-0.41 (95% CI: -0.56 to -0.27) for those with 1–2 pain sites, and -
0.61 (95% CI: -0.79 to -0.44) for those with ≥ 3 pain sites at baseline). As presented in Web 
table 1, results from the age- and sex-adjusted linear regression analyses do not differ 
distinctly from the fully adjusted analyses. The results from supplementary analyses using 
ordered logit regression are in line with the results presented above (see Web table 2).  
 
     Table 3 
   
The fixed effect within-subject analysis (Table 4) comprised 26,875 individuals with 48,669 
observations and gave largely similar results for anxiety and depression symptoms, problems 
initiating or maintaining sleep, and exercise as those presented in Table 3. However, the 
within-subject analysis showed weaker associations for changes in alcohol frequency, 
smoking, and BMI than those reported for the total sample. The number of pain sites in the 
within-subject analysis remained relatively unchanged over 11 years, with a decrease of -0.07 
(95%: CI -0.11 to -0.04) pain sites. 
 
     Table 4 
 
Discussion 
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This study showed that regardless of pain extent at baseline, symptoms of anxiety and/or 
depression, sleeping problems, smoking, and obesity were associated with an increase in the 
number of pain sites at follow-up, whereas education was associated with a decrease in the 
number of pain sites. Physical activity showed a weak inverse association with number of 
pain sites, but only among people reporting baseline pain. Except for anxiety and depression 
symptoms, and sleeping problems, these associations were attenuated in the within-subject 
analysis. On average, the number of pain sites reported by participants remained unchanged 
over 11 years. 
 
Relevance to other studies 
Using data from the HUNT study, previous studies have examined prevalence of pain and 
potential associations between number of pain sites, body pain locations, or CWP, versus 
physical and psychosocial risk factors.18, 40, 42, 44 However, we have not found comparable 
studies that have examined the association between pain development and these risk factors 
on the basis of different levels of reported baseline pain sites, or examined how these factors 
influence possible long-term changes in pain sites within individuals.  
 
Our study indicated no substantial change in number of pain sites between the two surveys 
performed in the mid-1990s and 2000s. A UK study22 suggested an increased prevalence of 
musculoskeletal pain in the general population, based on results from two surveys conducted 
over 40 years apart. Other studies over shorter time spans reported results more similar to our 
own.25 The minor differences in number of pain sites between the two surveys is also in line 
with the results from a Norwegian study18 based on the same material as the present study, 
which indicated a small but statistically significant increase in the prevalence of chronic 
musculoskeletal complaints in HUNT2 compared to HUNT3. The differences between the 
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conclusions may be due to different designs and methodological approaches, i.e. cross-
sectional prevalence study against our prospective study examining possible changes in pain 
sites using multilevel within-subject regression analyses. In population studies, chronic pain 
might not occur among the same people at each time point. Thus, within-subject analysis is 
less biased and gives a stronger indication of the relationship.  
 
Others have examined a classification for multisite pain patterns, demonstrating that pain 
involving 6–10 body sites yielded a stronger association with physical and psychosocial risk 
factors than having 1–3 pain sites or CWP.8 In this study, we examined potential   
associations between risk factors and change in pain on the basis of three baseline pain 
categories: no pain, 1–2 pain sites, and 3 or more pain sites. Thus we could include but not 
limit the study to those with pain consistent with CWP according to the ACR criteria.53  
 
The present study demonstrates that having anxiety or both anxiety and depression were 
strongly associated with increased pain regardless of pain at baseline, although this was 
particularly evident in those with no chronic pain at baseline. Chronic pain is a complex 
perceptual experience, often comorbid with anxiety and depression and determined by 
sensory and social influences.13,26 Emotional distress is commonly observed in people with 
chronic pain, and it may also predispose an individual to experience pain.13 A prospective 
Dutch study examined the impact of pain on depression and anxiety onset and found that only 
joint pain and increasing number of pain locations (but not pain duration) were associated 
with depression and anxiety onset.14 Notwithstanding the co-occurrence of chronic pain and 
psychological symptoms, the onset of pain and mild psychological symptoms do not typically 
coincide, and could be mutually independent.9 We also found that baseline sleeping problems 
were most positively associated with the number of pain sites at follow-up among those 
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reporting 3 or more pain sites, which is consistent with previous studies reporting sleep 
problems as a risk factor for CWP persistence and development 43, 45  
Regarding the frequency of alcohol use, our results suggest a modest preventive effect of 
moderate alcohol use on number of pain sites at follow-up among those with baseline pain, 
compared to alcohol abstinence. This is consistent with other studies examining risk factors 
for CWP development,3, 45 and may be explained by possible biological3 or confounding 
effects of other health and lifestyle concerns. Consistent with previous studies,43, 45 we found 
that obesity was associated with both the development and persistence of chronic pain. 
Similarly, several prospective studies have found some evidence that being overweight and 
obese are risk factors for chronic pain because weight gains increase strains, especially in 
joints.22, 50 Former and current smoking are also associated with a prospective increased pain 
among those with no pain or 1–2 pain sites at baseline. However, this relationship is denoted 
as complex because of possible mediating factors between smoking and pain, such as 
depression symptoms.15,16 In those with baseline pain, physical activity was weakly associated 
with a subsequent decrease in pain. Current public health recommendations are an average of 
30 minutes of moderate to intense daily physical activity, which is supposed to provide 
substantial benefits across a wide range of health outcomes.5 Others have also found evidence 
of a robust relationship between exercise and pain.34  
 
Our study showed that education at the university/college level was inversely associated with  
number of pain sites at follow-up, and particularly among those with 3 or more pain sites. 
Education has been considered as the best indicator of socioeconomic status (SES),19 and low 
SES has been associated with increased mortality and morbidity.38 However, the association 
between chronic pain and educational level may be merely a part of a more complex picture.6 
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Because we did not examine occupation or other corresponding social factors, we may not 
have fully grasped the nature of this relationship. 
 
The within-subject associations between the number of pain site changes and measures of 
anxiety or depression were attenuated, while the associations with lifestyle factors dissolved 
compared with the population analyses. Even though high BMI and previous smoking have 
been associated with risk of chronic pain,22, 32, 45, 56 our results indicate that these risk factors 
could be influenced by time-lagged effects, i.e. they must have been present for some time in 
order to result in a change in the number of pain sites. The results may also be explained from 
the fixed-effect analyses, where each person is her/his own control and where bias caused by 
unmeasured time-invariant confounding effects, such as individual personality traits, ability, 
SES, and genetics, can be avoided.17 With repeated measures of both the exposure and 
outcome, only within-individual changes over time were analysed, eliminating between-
individual differences that may be present in the population analyses.  
 
Strengths and limitations  
Major strengths of this study are the large population base and sample size, and the 11-year 
span between HUNT2 and the follow-up in HUNT3. The prospective design and length of 
follow-up are useful for determining possible causal directions of health-related and lifestyle 
factors and the association with prospective changes in pain sites. Complete baseline and 
follow-up data from this large sample also indicates high validity. Using standardized and 
comparable questions to collect pain data at two time points also ensures the comparability 
of results across different studies. 
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While approximately 70% of those invited to HUNT2 participated, 54% of those invited to 
HUNT3 participated, representing an attrition of 15%. The lower response rate in HUNT3 
may have affected the prevalence estimates of chronic pain at follow-up and thus implied a 
loss of accuracy in population estimates and threatened external validity.33, 48 Non-participants 
in HUNT3 had a lower socioeconomic status and higher mortality, along with higher rates of 
smoking and physical inactivity, and a higher prevalence of several chronic diseases.36 For 
those who participated, different patterns were found for problems like musculoskeletal pain, 
urine incontinence, and headache, which might have affected the prevalence estimates of pain 
in HUNT3.36 This might also indicate that pain is not an important cause of non-participation. 
However, low participation rates do not necessarily indicate a high level of bias inherent in a 
study.12, 36, 41 
 
Conclusions and implications 
This large 11-year follow-up study demonstrates that risk factors for change in the number of 
pain sites over time are not exclusively dependent on pain extent at baseline. However, having 
anxiety and depression symptoms, sleeping problems, and being obese, were the most 
important predictors of an increase in number of pain sites reported over time. To better 
understand risk factors for worsening pain or indeed factors for reducing pain over time,  
socioeconomic, lifestyle, and health-related factors should be studied more extensively within 
individuals. A standardised approach to counting and classifying number of pain sites would 
allow for further comparison between studies and an ability to pool study data for a more 
powerful analysis. For a population approach, there is a need for perspectives expressed in 
terms of risk and probability. To improve clinical pain management, pain should be examined 
from prospectively collected data both among adolescence and adults in clinical and 
population-based samples, and in association with how pain interferes with daily function.   
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Table 1: Sample characteristicsa of HUNT2 (1995-1997) and HUNT3 (2006-2008) cohort   
 HUNT2  n=65.237 HUNT3 n=50.807 
Sex  Female (%)          34,662 (53)           27,758 (55) 
        Males  (%)          30,575 (47)           23,049 (45) 
HADS score    (%)         
    No anxiety or depression 48.811 (80) 32.822 (81) 
    Depression, not anxiety 3.032 (5) 1.907 (5) 
    Anxiety, not depression   5.864 (10) 3.789 (9) 
    Anxiety and depression 3.639 (6) 2.000 (5) 
Sleeping difficulties       (%)          
    No sleep problems  46.497 (86) 33.031 (82) 
    Sleep problems 7.883 (14) 7.383 (18) 
Alcohol use  (%)         
    0 times/month 16.970 (28) 11.852 (24) 
    1-7 times/month 33.013 (54) 28.092 (57) 
    ≥8 times/month 3.420 (6) 7.547 (15) 
    Abstainers 8.100 (8) 2.051 (4) 
Body mass index  (%)         
    Underweight 458 (0.7) 312 (0.6) 
    Normal  25.308 (39) 16.169 (32) 
    Overweight 27.973 (43) 22.358 (44) 
    Obesity 10.722 (17) 11.575 (23) 
Smoking status  (%)         
    Never smoker 27.761 (44) 21.053 (43) 
    Former smoker 17.489 (27) 11.116 (33) 
    Current smoker 18.535 (29) 12.209 (25) 
Physical activity  (%)         
    Inactive 35.408 (61) 17.984 (45) 
    Active 22.851 (39) 21.606 (55) 
Marital status  (%)         
    Not married  28.920 (41) 29.174 (44) 
    Married/cohabitant 41.203 (59) 36.900 (56) 
Education  (%)         
    Primary school 22.687 (37) N/A 
    High school 26.772 (43) N/A 
    College/university 12.311 (20) N/A 
Chronic disease  (%)         
     No  44.717  (74) 32.368 (66) 
     Yes 15.851 (26) 16.760 (34) 
Number of pain sites  (%)         
     0 33.997 (52) 19.105 (48) 
     1 6.470 (10) 4.445 (11) 
     2 6.931  (11) 4.667 (12) 
     3 5.328  (8) 3.887 (10) 
     4 4.092 (6) 2.955 (7) 
     5 2.746 (4) 1.865 (5) 
     6 1.840 (3) 1.201 (3) 
     7 1.354 (2) 808 (2) 
     8 971 (1.5) 514 (1.3) 
     9 1.244 (2) 680 (2) 
Abbreviations: N/A = not available 
aGiven as number and percentage (%) 
Because of rounding errors, percentages do not sum to 100 
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Table 2. Stabilitya in number of pain sites from HUNT2 (1995-1997) to HUNT3 (2006-2008) 
 Number of pain-sites (%) in HUNT3 (2006-2008)  
Number of pain sites 
in HUNT2 (1995-1997)  
0 1-2 ≥3 
0 9,686 (62) 3,526 (22) 2,479 (16) 
1-2 2,392(39)         1,926 (32) 1,837 (30) 
≥3 1,557(19)        1,546 (18) 5,313 (63)         
aGiven as number and percentage (%) 
Because of rounding errors, percentages do not sum to 100  
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Table 3: Mean differences in number of pain sites in HUNT3 (2006-08) according to different risk factors reported in HUNT2 (1995-97), 
conditional on baseline number of pain sites 
 No pain  1-2 pain sites  3+ pain sites 
Risk factors Mean 
differencea 
95% CI  Mean 
differencea 
95% CI  Mean 
differencea 
95% CI 
HADS score                  
    No anxiety or depression, cut-off score <8 0.00 Reference  0.00 Reference  0.00 Reference 
    Depression, not anxiety, cut-off score  ≥8 0.15 -0.01 to 0.31  0.22 -0.04 to 0.48  0.17 -0.09 to 0.43 
    Depression, dimensional variable 0.04 0.03 to 0.06  0.04 0.02 to 0.06  0.03 0.01 to 0.06 
    Anxiety, not depression, cut-off score  ≥8 0.40 0.30 to 0.50  0.21 0.04 to 0.38  0.45 0.28 to 0.62 
    Anxiety, dimensional 0.06 0.05 to 0.07  0.05 0.04 to 0.07  0.05 0.03 to 0.07 
    Anxiety and depression ,cut-off score  ≥8 0.54 0.38 to 0.70  0.33 0.09 to 0.56  0.44 0.24 to 0.64 
    HADS total score, dimensional variable 0.03 0.03 to 0.04  0.03 0.02 to 0.04  0.03 0.01 to 0.04 
Sleeping difficulties                
    No sleep problems  0.00 Reference  0.00 Reference  0.00 Reference 
    Sleep problems 0.38 0.27 to 0.49  0.34 0.18 to 0.50  0.56 0.41 to 0.71 
Alcohol use         
    0 times/month 0.00 Reference  0.00 Reference  0.00 Reference 
    1-7 times/month -0.04 -0.11 to 0.02  -0.13 -0.26 to -0.01  -0.11 -0.25 to 0.03 
    ≥8 times/month -0-04 -0.16 to 0.08  -0.24 -0.46 to -0.02  -0.29 -0.56 to -0.01 
    Abstainers -0.07 -0.18 to 0.04  -0.06 -0.26 to 0.15  0.07 -0.15 to 0.30 
Body mass index         
   Normal weight,   18.5 to 24.9 kg/m2  0.00 Reference  0.00 Reference  0.00 Reference 
    Underweight,    <18.5 kg/m2 0.14 -0.20 to 0.47  0.42 -0.29 to 1.13  -0.10 -0.93 to 0.72 
    Overweight,        25 to 29.9 kg/m2 0.14 0.08 to  0.20  0.12 0.02 to 0.23  0.12 -0.01 to 0.25 
    Obesity,            ≥30 kg/m2 0.30 0.21 to 0.38  0.18 0.02 to 0.34  0.44 0.28 to 0.61 
Body mass  index, dimensional variable 0.03 0.02 to 0.03  0.02 0.01 to 0.04  0.04 0.02 to 0.06 
Smoking status         
    Never smoker 0.00 Reference  0.00 Reference  0.00 Reference 
    Former smoker 0.20 0.13 to 0.26  0.21 0.09 to 0.33  0.19 0.05 to 0.33 
    Current smoker 0.26 0.20 to 0.33  0.32 0.19 to 0.45  0.13 -0.02 to 0.27 
Physical activity         
    Inactive 0.00 Reference  0.00 Reference  0.00 Reference 
    Active -0.05 -0.12 to 0.02  -0.15 -0.25 to -0.05  -0.12 -0.24 to – 0.00 
Education         
    Primary school 0.00 Reference  0.00 Reference  0.00 Reference 
    High school -0.05 -0.12 to 0.02  -0.01 -0.14 to 0.11  -0.10 -0.23 to 0.03 
    College/university -0.30 -0.38 to -0.22  -0.41 -0.56 to -0.27  -0.61 -0.79 to -0.44 
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aAdjusted for age, sex, chronic disease, marital status, as well as education and physical activity in analyses where these variables are not the main 
variable of interest
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Table 4. Mean change in number of pain sites in HUNT2 (1995-97) and HUNT3 (2006-08) according to change 
in different risk factors. Within individual fixed effect linear regression analyses.  
a Adjusted for physical activity and chronic disease were these variables are not the main variable of interest 
 
 
 
 
 
 
 
 
 
 
Risk factors Within-subjects N=26,875 individuals in 48,669 observations 
 Mean changea 95% CI 
HADS score            
       No anxiety or depression Ref.  
       Depression, not anxiety  0.17          0.06 to 0.28 
       Anxiety, not depression  0.23           0.15 to 0.32 
       Anxiety and depression  0.46            0.34 to 0.57 
Sleeping difficulties          
        No sleep problems Ref.  
        Sleep problems  0.31           0.25 to 0.38 
Smoke status,  never smoking    Ref.  
         ex. smoker  0.11           -0.04 to 0.26 
         current daily smoker  0.11           -0.05 to 0.26 
BMI normal 18.5-24.9 kg/m2  Ref.  
         underweight <18.5 kg/m2 -0.09          -0.45 to 0 .27 
         overweight 25-29.9  kg/m2  0.08           0.01 to 0.14 
         obese ≥30 kg/m2  0.14           0.04 to 0.25 
Alcohol-monthly use, 0 time a month  Ref.  
       1-7 times a month  0.05           -0.02 to 0.11 
       8  times or more a month -0.04           -0.14 to 0.06 
        abstainers -0.03           -0.16 to 0.10 
Physical activity    
        inactive Ref.  
        active  0.03          -0.08 to 0.01 
Pain-sites  from HUNT2 to HUNT3  -0.07                                          -0.11 to  -0.04 
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